%0
Generic
%T
Investigation of the HDAC inhibitor resminostat in patients with sorafenib-resistant hepatocellular carcinoma (HCC): Clinical data from the phase I/II SHELTER study.
%A Bitzer, Michael
%A Horger, Marius
%A Ganten, Tom M
%A Siveke, Jens T
%A Woerns, Marcus A
%A Dollinger, Matthias M.
%A Gerken, Guido
%A Scheulen, Max E.
%A Wege, Henning
%A Giannini, Edoardo G
%A Montesarchio, Vincenzo
%A Mais, Anna
%A Jankowsky, Rüdiger
%A Hauns, Bernhard
%A Hentsch, Bernd
%A Lauer, Ulrich
%I American Society of Clinical Oncology (ASCO)
%@ 0732-183X
%@ 1527-7755
%K Cancer Research
%K Oncology
%D 2012
%C American Society of Clinical Oncology (ASCO)
%U http://slubdd.de/katalog?TN_libero_mab2